Immediate Impact
1 from Science/Nature 61 standout
Citing Papers
The present and future of bispecific antibodies for cancer therapy
2024 Standout
The pathogenesis of Parkinson's disease
2024 Standout
Works of Ira Goodman being referenced
Randomized phase I clinical trial of anti–α‐synuclein antibody BIIB054
2019
Safety and Tolerability of Multiple Ascending Doses of PRX002/RG7935, an Anti–α-Synuclein Monoclonal Antibody, in Patients With Parkinson Disease
2018
Author Peers
| Author | Last Decade | Papers | Cites | ||||
|---|---|---|---|---|---|---|---|
| Ira Goodman | 320 | 167 | 29 | 150 | 11 | 436 | |
| Eileen H. Bigio | 202 | 148 | 22 | 163 | 11 | 431 | |
| Barbara Wilmarth | 273 | 163 | 42 | 135 | 9 | 438 | |
| Emily S. Meymand | 255 | 94 | 26 | 240 | 9 | 422 | |
| Abigail Lawler | 254 | 156 | 61 | 163 | 8 | 479 | |
| Zheng‐Tong Ding | 367 | 146 | 17 | 118 | 20 | 500 | |
| Kevin McFarthing | 245 | 156 | 28 | 87 | 22 | 430 | |
| Hiroyuki Sumikura | 240 | 99 | 15 | 130 | 18 | 389 | |
| Núria Setó‐Salvia | 199 | 98 | 15 | 183 | 9 | 458 | |
| Peng Wang | 262 | 124 | 13 | 94 | 9 | 434 | |
| Sandrine Greffard | 305 | 131 | 7 | 70 | 12 | 379 |
All Works
Login with ORCID to disown or claim papers
Loading papers...